rly-2608
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Dec 8, 2021 (NCT05216432)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
N#Cc1c(-c2cc(NC(=O)c3cc(F)cc(C(F)(F)F)c3)c3c(c2)C(=O)N[C@H]3c2cc(F)ccc2Cl)ccc2ncnn12- Mol. weight
- 608.91 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6068523 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06982521 | Phase 3 | Aug 26, 2025 | Relay Therapeutics, Inc. |
| NCT06789913 | Phase 2 | Mar 31, 2025 | Relay Therapeutics, Inc. |
| NCT05216432 | Phase 1 | Dec 8, 2021 | Relay Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. | For profit | 3 | 3 | 3 | 2021 |
1 organizations
Page 1 / 1